Your browser doesn't support javascript.
loading
Enhancing value of quality assurance rounds in improving radiotherapy management: a retrospective analysis from King Hussein Cancer Center in Jordan.
Khader, Jamal K; Al-Mousa, Abdelatif M; Mohamad, Issa A; Abuhijlih, Ramiz A; Al-Khatib, Sondos A; Alnsour, Anoud Z; Asha, Wafa A; Ramahi, Shada W; Hosni, Ali A; Abuhijla, Fawzi J.
Afiliação
  • Khader JK; Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan.
  • Al-Mousa AM; Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan.
  • Mohamad IA; Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan.
  • Abuhijlih RA; Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan.
  • Al-Khatib SA; Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan.
  • Alnsour AZ; Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan.
  • Asha WA; Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan.
  • Ramahi SW; Department of Biomedical Physics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Hosni AA; Department of Radiation Oncology, Princess Margaret Cancer Centre, Toronto, Canada.
  • Abuhijla FJ; Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan.
Radiat Oncol J ; 37(1): 60-65, 2019 Mar.
Article em En | MEDLINE | ID: mdl-30947482
ABSTRACT

PURPOSE:

The quality assurance (QA) chart rounds are multidisciplinary meetings to review radiation therapy (RT) treatment plans. This study focus on describing the changes in RT management based on QA round reviews in a single institution. MATERIALS AND

METHODS:

After 9 full years of implementation, a retrospective review of all patients whose charts passed through departmental QA chart rounds from 2007 to 2015. The reviewed cases were presented for RT plan review; subcategorized based on decision in QA rounds into approved, minor modifications or major modifications. Major modification defined as any substantial change which required patient re-simulation or re-planning prior to commencement of RT. Minor modification included treatment plan changes which didn't necessarily require RT re-planning.

RESULTS:

Overall 7,149 RT treatment plans for different anatomical sites were reviewed at QA rounds. From these treatment plans, 6,654 (93%) were approved, 144 (2%) required minor modifications, while 351 (5%) required major modifications. Major modification included changes in selected RT dose (96/351, 27%), target volume definition (127/351, 36%), organs-at-risk contouring (10/351, 3%), dose volume objectives/constraints criteria (90/351, 26%), and intent of treatment (28/351, 8%). The RT plans which required major modification according to the tumor subtype were as follows head and neck (104/904, 12%), thoracic (12/199, 6%), gastrointestinal (33/687,5%), skin (5/106, 5%), genitourinary (16/359, 4%), breast (104/2387, 4%), central nervous system (36/846, 4%), sarcoma (11/277, 4%), pediatric (7/251, 3%), lymphoma (10/423, 2%), gynecological tumors (2/359, 1%), and others (11/351, 3%).

CONCLUSION:

Multi-disciplinary standardized QA chart rounds provide a comprehensive and an influential method on RT plans and/ or treatment decisions.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Radiat Oncol J Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Jordânia

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Radiat Oncol J Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Jordânia